Breast Edema Following Breast-Conserving Surgery and Radiotherapy: Patient-Reported Prevalence, Determinants, and Effect on Health-Related Quality of Life

Author:

Young-Afat Danny A12,Gregorowitsch Madelijn L1,van den Bongard Desirée H3,Burgmans Ine4,van der Pol Carmen C5,Witkamp Arjen J6,Bijlsma Rhodé M7,Koelemij Ron8,Schoenmaeckers Ernst J9,Jonasse Yvette10,van Gils Carla H211,Verkooijen Helena M111

Affiliation:

1. Imaging Division, University Medical Center, Utrecht, the Netherlands

2. Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands

3. Department of Radiation Oncology, University Medical Center, Utrecht, the Netherlands

4. Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands; Department of Surgery, Diakonessenhuis, Utrecht, the Netherlands

5. Department of Surgery, Alrijne Hospital, Leiderdorp, the Netherlands

6. Department of Surgery, University Medical Center, Utrecht, the Netherlands

7. Department of Medical Oncology, University Medical Center, Utrecht, the Netherlands

8. Department of Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands

9. Department of Surgery, Meander Medical Center, Amersfoort, the Netherlands

10. Alexander Monro Hospital, Bilthoven, the Netherlands

11. Utrecht University, Utrecht, the Netherlands

Abstract

Abstract Background The association between lymphedema of the arm and impaired health-related QoL (HR-QoL) has led to changes in clinical practice. However, data on lymphedema of the breast (ie, breast edema) are lacking. We prospectively evaluated patient-reported prevalence and determinants of breast edema and its effect on patient-reported HR-QoL and breast pain. Methods We prospectively included 836 patients undergoing breast-conserving surgery followed by radiotherapy between October 2013 and October 2016 (UMBRELLA cohort). Patient-reported breast edema, HR-QoL, and breast pain were assessed by means of European Organisation for Research and Treatment of Cancer-C30/BR23 before starting radiotherapy and at 3, 6, 12, and 18 months thereafter. We assessed which patient, tumor, and treatment characteristics were associated with breast edema. With mixed-effects models, we assessed the impact of breast edema on patient-reported HR-QoL domains and breast pain over time, adjusting for confounders. Results Within a median follow-up of 28 months (interquartile range [IQR] = 15), 207 (24.8%) patients reported breast edema at some point in time. Prevalence of breast edema was highest at 6 months (12.4%, 95% confidence interval [CI] = 10.0 to 14.7). Larger tumor size, oncoplastic surgery, axillary lymph node dissection, locoregional radiotherapy, radiotherapy boost on the tumor bed, and adjuvant chemotherapy were associated with breast edema. Breast edema was independently associated with more breast pain and with poorer QoL, physical functioning, and body image. Conclusions Breast edema occurs frequently within the first year after breast-conserving surgery and radiotherapy and is independently associated with impaired HR-QoL and more breast pain. This information is important for use in clinical practice and should be discussed with patients during shared decision making.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference30 articles.

1. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2011

2. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial;Litière;Lancet Oncol,2012

3. Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period;Bosma;Breast Cancer Res Treat,2016

4. Psychosocial/survivorship issues in breast cancer: are we doing better?;Fallowfield;J Natl Cancer Inst,2015

5. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline;Runowicz;CA Cancer J Clin,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3